Cencora, Inc. (COR)

Cencora, Inc. has an AlphaScore of 40/100 within the Healthcare sector based on the October 11, 2026 snapshot. Data highlights include strong revenue growth of 9.31 and an exceptionally high return on equity of 103.06. A key strength is its strong top-line expansion rate. Conversely, a critical risk is the high debt-to-equity ratio of 5.08 alongside a thin net margin of 0.48. Evidence is limited solely to this dataset.

Written 11/10/2026, 00:42:18 UTC · Snapshot 11/10/2026